Mangoceuticals (US:MGRX) — Company Overview, News & Financial Data
Mangoceuticals is focused on developing innovative pharmaceutical and healthcare products that address unmet medical needs.
Mangoceuticals
Mangoceuticals (NASDAQ:MGRX) focuses on the development and commercialization of innovative pharmaceutical and healthcare products. With a diverse portfolio that spans from groundbreaking therapies to wellness products, Mangoceuticals aims to improve the quality of life by addressing unmet medical needs. Its projects range from early-stage drug discovery to advanced clinical trials, targeting a variety of therapeutic areas. Besides its primary listing, Mangoceuticals is committed to expanding its impact, striving to become a household name in health and wellness solutions while maintaining a strong ethical framework and sustainability in its operations.
Snapshot
Operations
Products and/or services of Mangoceuticals
- Development of innovative oncology treatments targeting rare and difficult to treat cancers.
- Research and production of advanced skincare products incorporating novel biotech ingredients.
- Partnership initiatives for global distribution of its patented pharmaceutical products.
- Creation of a state-of-the-art biotechnology research facility focused on genetic and cell therapy.
- Investment in AI-driven drug discovery platforms to accelerate the development of new medications.
- Launching a telemedicine service offering personalized healthcare consultations and prescription services.
Mangoceuticals executive team
- Mr. Jacob D. CohenCo-Founder, CEO & Chairman
- Mr. Eugene M. JohnstonChief Financial Officer